Recent studies infer that systemic glucose profiles are a crucial determinant of Ghrh neuromodulation of counterregulatory transmitter marker mRNA expression, as insulin (INS)-induced hypoglycemia (IIH) is associated with gain or loss of Ghrh control of distinctive marker gene profiles [15]. The gene discussed is INS; the disease is Hypoglycemia.